Jess G Fiedorowicz1, Lorick E Andersen, Jane E Persons, Chadi Calarge. 1. Department of Psychiatry, Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA USA, Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA USA. E-mail: jess-fiedorowicz@uiowa.edu.
Abstract
BACKGROUND: Persons with bipolar disorder represent a high-risk group for obesity, but little is known about the time course by which weight gain occurs in bipolar disorder. METHODS: We prospectively studied changes in fat distribution using dual-energy x-ray absorptiometry in relationship to medication exposure and mood symptom burden in 36 participants with bipolar disorder. We assessed the relationship between prior medication exposure and course of illness with adiposity measures at baseline (N = 36) and at 6-month follow-up (N = 22). RESULTS: At baseline, greater adiposity was associated with advanced age and female sex, not retrospectively assessed symptom course or medication exposure (past 2 years). Over 6 months of prospective follow-up, participants developed greater adiposity (fat mass index +0.82 kg/m(²), P = .007; visceral fat area +8.6 cm(²), P = .02; total percent fat +1.6%, P = .02). Manic symptomatology, not antipsychotic exposure, was related to the increased adiposity. CONCLUSIONS: Acute exacerbations of mood disorders appear to represent high-risk periods for adipose deposition. Obesity prevention efforts may be necessary during acute exacerbations.
BACKGROUND:Persons with bipolar disorder represent a high-risk group for obesity, but little is known about the time course by which weight gain occurs in bipolar disorder. METHODS: We prospectively studied changes in fat distribution using dual-energy x-ray absorptiometry in relationship to medication exposure and mood symptom burden in 36 participants with bipolar disorder. We assessed the relationship between prior medication exposure and course of illness with adiposity measures at baseline (N = 36) and at 6-month follow-up (N = 22). RESULTS: At baseline, greater adiposity was associated with advanced age and female sex, not retrospectively assessed symptom course or medication exposure (past 2 years). Over 6 months of prospective follow-up, participants developed greater adiposity (fat mass index +0.82 kg/m(²), P = .007; visceral fat area +8.6 cm(²), P = .02; total percent fat +1.6%, P = .02). Manic symptomatology, not antipsychotic exposure, was related to the increased adiposity. CONCLUSIONS: Acute exacerbations of mood disorders appear to represent high-risk periods for adipose deposition. Obesity prevention efforts may be necessary during acute exacerbations.
Authors: Jess G Fiedorowicz; William H Coryell; John P Rice; Lois L Warren; William G Haynes Journal: Psychother Psychosom Date: 2012-05-11 Impact factor: 17.659
Authors: Lisa K Micklesfield; Julia H Goedecke; Mark Punyanitya; Kevin E Wilson; Thomas L Kelly Journal: Obesity (Silver Spring) Date: 2012-01-12 Impact factor: 5.002
Authors: W Swardfager; M Hennebelle; D Yu; B D Hammock; A J Levitt; K Hashimoto; A Y Taha Journal: Neurosci Biobehav Rev Date: 2018-02-02 Impact factor: 8.989
Authors: Jess G Fiedorowicz; Lisa Brown; James Li; Sagar V Parikh; Boadie W Dunlop; Brent P Forester; Richard C Shelton; Michael E Thase; Matthew Macaluso; Kunbo Yu; John F Greden Journal: Psychopharmacol Bull Date: 2021-11-03
Authors: Lucas B Rizzo; Walter Swardfager; Pawan Kumar Maurya; Maiara Zeni Graiff; Mariana Pedrini; Elson Asevedo; Ana Cláudia Cassinelli; Moisés E Bauer; Quirino Cordeiro; Jan Scott; Elisa Brietzke; Hugo Cogo-Moreira Journal: Int J Methods Psychiatr Res Date: 2018-04-25 Impact factor: 4.035